Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result-out” Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. Our focus on food safety Roka delivers accurate and reliable test results for food pathogens regardless of sample type. You can be confident in the accuracy of your results, the efficiency of our automated system, and our commitment to you and the food safety industry. Roka is here to partner with food manufacturers and help them reach the next level of food safety testing.
Company Growth (employees)
Warren, US
Size (employees)
90 (est)
Roka Bioscience was founded in 2009 and is headquartered in Warren, US

Key People at Roka Bioscience

Paul G. Thomas

Paul G. Thomas

Founder , CEO & Board Member
David R. Patterson

David R. Patterson

Vice President of Manufacturing Operations
Wally Narajowski

Wally Narajowski

Senior Vice President / General Manager
Dan Behler

Dan Behler

Vice President of Marketing
A.J. McCardell

A.J. McCardell

Senior Vice President, Commercial Operations
Lars Boesgaard

Lars Boesgaard

Vice President of Finance

Roka Bioscience Office Locations

Roka Bioscience has office in Warren
Warren, US

Roka Bioscience Metrics

Roka Bioscience Summary

Market capitalization

$12.4 m

Closing share price

Roka Bioscience's current market capitalization is $12.4 m.

Roka Bioscience Financials

Roka Bioscience's revenue is $6 m in FY, 2015 which is a 18.4% increase from the previous period.
FY, 2014FY, 2015


$5.1 m$6 m

Revenue growth, %


Gross profit

($2.8 m)($1.7 m)

Operating expense total

$36.6 m$41.3 m


($31.6 m)($35.3 m)

Net Income

($32.2 m)($36.6 m)

Operating cash flow

($25.2 m)($4.1 m)

Roka Bioscience Market Value History

We estimate that Roka Bioscience's current employees are approximately 10% female and 90% male.

Roka Bioscience Online Presence

Roka Bioscience News

Roka Bioscience Company Life

You may also be interested in